Grupo Supervielle Earnings Call Transcripts
Fiscal Year 2025
-
Q4 2025 saw strong corporate loan growth and margin recovery, with net losses narrowing sharply from Q3. Asset quality peaked but showed signs of stabilization, and digital transformation advanced. 2026 guidance anticipates robust loan and deposit growth, margin improvement, and a return to profitability as macro conditions normalize.
-
Third quarter 2025 saw a net loss due to high rates and regulatory pressures, but loan and deposit growth remained strong, led by corporates. Asset quality weakened, but cost controls and capital ratios stayed robust. Outlook for 2026 is optimistic, with expected loan growth and improving ROE.
-
Loan growth outpaced the market, led by commercial lending, while asset quality normalized and U.S. dollar deposits hit record highs. Net income rose 62% sequentially, with ROE at 6%, and guidance points to continued loan and deposit growth, stable asset quality, and improving ROE into 2026.
-
Retail lending drove loan growth and now exceeds half the portfolio, while NPL and cost of risk rose due to portfolio mix but remain within guidance. Net financial income was pressured by investment portfolio losses, but cost discipline and digital initiatives support improved ROE outlook for 2025.
Fiscal Year 2024
-
2024 saw robust loan and deposit growth, digital transformation, and strong profitability, with retail lending and digital brokerage driving results. 2025 guidance anticipates continued loan expansion, lower NIM, and stable asset quality, with capital ratios expected to decline as growth accelerates.
-
Loan and deposit growth accelerated, with retail and digital channels driving expansion. Asset quality remains strong, and full-year ROE guidance of 15% is maintained as macro conditions improve and capital ratios remain robust.
-
Loan growth surged 36% sequentially, driving market share gains and a record low NPL ratio, while net income and ROE rose sharply year-over-year. Guidance calls for over 40% real loan growth in 2024, with ROE expected to normalize to 15% and CET1 to 17–20% by year-end.